期刊文献+

小剂量托吡酯治疗小儿Tourette综合征疗效的初步观察 被引量:4

Observation on Curative Effect of Tourette Syndrome Treated with Topiramate
下载PDF
导出
摘要 目的探讨托吡酯治疗小儿Tourette综合征(TS)的临床效果与合适剂量。方法本组40例儿童随机分为治疗组21例和对照组19例,两组均在心理治疗基础上进行药物治疗。治疗组采用托吡酯,剂量从0.5 mg/kg,1次/d开始,第2周增加1.0 mg/(kg.d),分2次服用,以后每1~2周增加0.5 mg/kg,最大剂量为3.0 mg/(kg.d),用药3个月后,依据抽动控制情况评定疗效,并观察药物不良反应;对照组采用氟哌啶醇4.0~12 mg/d,2次/d口服,治疗期间定期门诊复诊。结果治疗组有效率95.6%,对照组有效率85%,两组有效率比较有显著差异。结论小剂量托吡酯治疗TS比氟哌啶醇更有效,且副作用明显小。 Objective To discuss curative effect and dosage of topiramate to treat Tourette syndrome.Methods 40 cases of such patient were divided into therapy group(21 cases) and control group(19 cases).On the bases of psychotherapy,the control group was treated with vesalium 4.0~12 mg/d bid.And therapy group was treated with topiramate of dosage from 0.5 mg/kg/d,to 1.0 mg/kg twice a day,and increased 0.5 mg/kg every one or two week to 3.0 mg/kg/d for 3 months.The curative effect and spasm condition were observed and followed in OPD.Results The effective rate was 95.6% in therapy group and 85% in control group with significant difference between two groups.Conclusion The small dosage of topiramate might have better curative effect with less side effect.
出处 《黑龙江医学》 2011年第10期766-768,共3页 Heilongjiang Medical Journal
关键词 托吡酯 氟哌啶醇 TOURETTE综合征 Topiramate Vesalium TS
  • 相关文献

参考文献7

二级参考文献13

  • 1吴家骅.DSM-Ⅳ关于抽动障碍的分类与诊断标准[J].中华儿科杂志,1996,34(5):352-352. 被引量:110
  • 2Abuzzahab FS, Brown VL.Control of Tourette′s syndrome with topiramate. Am J Psychiatry, 2001, 158:968.
  • 3Leckman JF, Riddle MA, Hardin MT, et al . The Yale Global Tic Severity Scale: initial testing of a clinician-rated scale of tic severity. J Am Acad Child Adolesc Psychiatry, 1989, 28: 566-574.
  • 4Erenberg G, Cruse RP, Rothner AD. The natural history of Tourette syndrome: a follow-up study. Ann Neurol, 1987, 22:383-385.
  • 5Coulter DA, Sombati S, DeLorenzo RJ. Topiramate effects on excitatory amino acid mediated responses in cultured hippocampal neurons: selective blockade of kainite currents. Epilepsia, 1995, Suppl 3: S40-46.
  • 6Singer HS. Neurobiology of Tourette syndrome. Neurol Clin, 1997, 15:357-379.
  • 7Singer HS, Wendlandt J, Krieger M, Giuliano J. Baclofen treatment in Tourette syndrome: a double-blind, placebo-controlled, crossover trial. Neurology, 2001, 56:599-604.
  • 8Kurlan R.The pathogenesis of Tourette′s syndrome: a possible role for hormonal and excitatory neurotransmitter influences in brain development. Arch Neurol, 1992, 49:874-876.
  • 9Rudolph U, Crestani F, Benke D, et al. Benzodiazepine actions mediated by specific gamma-aminobutyric acid(A) receptor subtypes. Nature, 1999, 401:796-800.
  • 10刘智胜.抽动障碍患儿的药物治疗进展[J].国外医学(儿科学分册),1999,26(2):90-93. 被引量:7

共引文献65

同被引文献44

引证文献4

二级引证文献22

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部